RxCap has filed a notice of an exempt offering of securities to raise $21,156,047.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, RxCap is raising up to $21,156,047.00 in new funding. Sources indicate that as part of senior management President, Sreeram Ramakrishnan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About RxCap
RxCap provides medical prescription compliance and adherence products with data services to healthcare corporations. Through our broad hardware portfolio, platform and APIs, RxCap enables our clients to deliver intelligent care management services. RxCap can help Healthcare led conversations occur at the right time providing a significant human and cost improvement .
To learn more about RxCap, visit http://www.rxcap.com/
Contact:
Sreeram Ramakrishnan, President
415-254-7090
https://www.linkedin.com/in/sreeramramakrishnan/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.